Racial Variation in the Cost-effectiveness of Chemotherapy for Prostate Cancer
May 18th 2011The likelihood of chemotherapy being cost-effective for patients with metastatic prostate cancer differs across racial subgroups. This uncertainty presents challenges for managed-care decision makers.
Read More
2 Commerce Drive
Cranbury, NJ 08512